Cannabis Suisse Corp.
Cannabis Suisse Corp. (CSUI) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
csui · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 5 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Cannabis Suisse Corp.You CSUI | $1M | 6.18x | — | $0.00 |
 CENTR Brands Corp. CNTRF | $0M | N/A | — | -$0.03 |
 Elixinol Wellness Limited ELLXF | $1M | N/A | — | -$0.02 |
 Indocan Resources Inc. IDCN | $0M | N/A | — | — |
 Next Generation Management Corp. NGMC | $0M | N/A | — | -$325.72 |
 Nutra Pharma Corp. NPHC | $1M | N/A | — | -$0.00 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Cannabis Suisse Corp. (CSUI) measures how much investors pay for each dollar of the company's trailing earnings. CSUI's current PE ratio of 6.18x is calculated by dividing its stock price of $0.01 by its TTM earnings per share of $0.00.
Frequently asked questions
CSUI pe ratio · 6 questionsCSUI's current PE ratio is 6.18x as of 2026-06-09, based on a stock price of $0.01 and TTM EPS of $0.00. Data sourced from Financial Modeling Prep via CSUI's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Cannabis Suisse Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09